Skip to main content

Table 2 Information about participants’ CDG genotype, time until a final diagnosis, and professional and social support

From: Resilience in patients and family caregivers living with congenital disorders of glycosylation (CDG): a quantitative study using the brief resilience coping scale (BRCS)

 

Person living with CDG (N = 23)

Family caregiver (N = 151)

n

%

n

%

CDG genotype

PMM2-CDG

7

30.4

82

54.3

GNE myopathy

14

60.8

0

0.0

Other

2

8.8

69

45.7

Time until a final CDG diagnosis

 < 3 months

3

13.0

17

11.3

3–6 months

3

13.0

23

15.2

7–12 months

4

17.4

28

18.5

1–3 years

6

26.1

44

29.1

4–5 years

2

8.7

12

8.0

6–9 years

0

0

8

5.3

10–20 years

0

0

11

7.3

 > 20 years

4

17.4

8

5.3

I don’t know

1

4.3

0

0.0

Receive professional support (healthcare or other)

Yes

7

30.4

67

44.4

No

16

69.6

84

55.6

Contact with other families with a similar disease (CDG)

Yes

20

87.0

128

84.8

No

3

13.0

23

15.2